ADC Therapeutics SA

ADC Therapeutics SAverified

ADCT

Price:

$3.44

Market Cap:

$331.02M

ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical trial in combination with rituximab to treat relapsed or refractory DLBCL in second-line transplant-ineligible patients; and Phase I clinical trial for treatment of relapsed or refractory non-hodgkin lymphoma (NHL). The company is also developing camidanlumab tesirine, an ADC that has completed Phase I clinical trial to treat relap...[Read more]

Industry

Biotechnology

IPO Date

2020-05-18

Stock Exchange

NYSE

Ticker

ADCT

The PE Ratio as of July 2024 (TTM) for ADC Therapeutics SA (ADCT) is -1.24

According to ADC Therapeutics SA’s latest financial reports and current stock price. The company's current PE Ratio is -1.24. This represents a change of 34.67% compared to the average of -0.92 of the last 4 quarters.

ADC Therapeutics SA (ADCT) Historical PE Ratio (quarterly & annually)

How has ADCT PE Ratio performed in the past?

The mean historical PE Ratio of ADC Therapeutics SA over the last ten years is -8.39. The current -1.24 PE Ratio has changed 1.38% with respect to the historical average. Over the past ten years (40 quarters), ADCT's PE Ratio was at its highest in in the December 2018 quarter at 0. The PE Ratio was at its lowest in in the September 2020 quarter at -28.77.

Quarterly (TTM)
Annual

Average

-8.39

Median

-7.62

Minimum

-19.42

Maximum

0

ADC Therapeutics SA (ADCT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ADC Therapeutics SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 31.28%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -19.42

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.57-70.67%
2022-1.93-71.42%
2021-6.74-20.72%
2020-8.50-50.06%
2019-17.0231.28%
2018-12.97-33.23%
2017-19.42-Infinity%

ADC Therapeutics SA (ADCT) Average PE Ratio

How has ADCT PE Ratio performed in the past?

The current PE Ratio of ADC Therapeutics SA (ADCT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.08

5-year avg

-6.95

10-year avg

-8.39

ADC Therapeutics SA (ADCT) PE Ratio vs. Peers

How is ADCT’s PE Ratio compared to its peers?

ADC Therapeutics SA’s PE Ratio is less than Passage Bio, Inc. (-0.60), greater than Black Diamond Therapeutics, Inc. (-3.73), less than TCR2 Therapeutics Inc. (-0.44), greater than Harpoon Therapeutics, Inc. (-2.94), greater than Alector, Inc. (-4.53), less than Century Therapeutics, Inc. (-1.17), less than Homology Medicines, Inc. (-0.01), less than Generation Bio Co. (-1.13), greater than Stoke Therapeutics, Inc. (-5.79), greater than Ultragenyx Pharmaceutical Inc. (-5.85), greater than Crinetics Pharmaceuticals, Inc. (-16.17), greater than Arvinas, Inc. (-5.76), greater than Revolution Medicines, Inc. (-15.69), greater than Kura Oncology, Inc. (-10.46), greater than Akero Therapeutics, Inc. (-8.85), greater than Avidity Biosciences, Inc. (-17.21), less than Protagonist Therapeutics, Inc. (13.35), greater than Design Therapeutics, Inc. (-3.92), greater than ALX Oncology Holdings Inc. (-1.85), less than Aadi Bioscience, Inc. (-0.56), less than AlloVir, Inc. (-0.48),

Build a custom stock screener for ADC Therapeutics SA (ADCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ADC Therapeutics SA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ADC Therapeutics SA (ADCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ADC Therapeutics SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is ADC Therapeutics SA's PE Ratio?

How is the PE Ratio calculated for ADC Therapeutics SA (ADCT)?

What is the highest PE Ratio for ADC Therapeutics SA (ADCT)?

What is the 3-year average PE Ratio for ADC Therapeutics SA (ADCT)?

What is the 5-year average PE Ratio for ADC Therapeutics SA (ADCT)?

How does the current PE Ratio for ADC Therapeutics SA (ADCT) compare to its historical average?